Trial Information

Summary: An Investigational drug for Children with Acquired Attentional Disorders Following Completion of Chemotherapy for Acute Lymphocytic Leukemia

A Double-Blind, Placebo Controlled Trial for the Management of Chemotherapy-Related Acquired Attentional Disorders in Children who have Survived Acute Lymphocytic Leukemia (ALL)

We are currently conducting a research study for children and adolescents with chemotherapy-related acquired attentional disorders. Children and adolescents who survive ALL may experience school-related problems; specifically deficits in attention, reaction time, visual-motor coordination, memory and distractibility.

To be eligible to participate, your adolescent must:

• Be 6-18 years of age and weigh at least 44 pounds
• Have successfully completed treatment for ALL and are currently 1-year disease free as judged by the investigators
• Meet the criteria for attention deficit symptoms that have been precipitated by chemotherapy-related neurological injury
• Must be able to swallow tablets

All study related clinic visits, testing, and study medications are provided at no cost.

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.